Company profile: CathVision
1.1 - Company Overview
Company description
- Provider of novel hardware, software and data science solutions to guide ablation therapy of cardiac arrhythmia, including the ECGenius System for high-fidelity, low-noise electrogram acquisition; CARDIALYTICS for automated electrogram interpretation; PVI Analyzer and Signal Complexity visualization tools; and FaST Mapping, an AI-based algorithm in development.
Products and services
- CARDIALYTICS: Suite of AI-based algorithms engineered for intelligent electrogram interpretation, delivering automated analyses to support physicians in measuring ablation outcomes
- ECGenius System: Proprietary hardware amplifier that acquires high-fidelity, low-noise cardiac electrograms, aiding diagnosis and treatment of complex atrial arrhythmias during ablation therapy
- PVI Analyzer: AI-based algorithm that visualizes electrical isolation during pulmonary vein isolation procedures, aiming to improve the efficacy of ablation therapy
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CathVision
CiVi Biopharma
HQ: United States
Website
- Description: Provider of clinical-stage biotechnology research and development focused on novel cardiovascular therapies, including CiVi 008, an oral PCSK9-targeting treatment to lower LDL cholesterol and prevent atherosclerotic cardiovascular disease, and CiVi 030, an intravenous iloprost formulation for severe frostbite with vasodilator, platelet inhibitor, anti-inflammatory, and anti-fibrotic effects.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CiVi Biopharma company profile →
Scanadu
HQ: United States
Website
- Description: Provider of mobile medical devices, including Scanadu Scout for checking vital signs and Scanaflo, an at-home urine analysis test with results viewable on a smartphone.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Scanadu company profile →
Mezzion Pharma
HQ: United States
Website
- Description: Provider of pharmaceuticals developing and discovering medicines, including JURVIGO (udenafil), a medication to improve physiology and exercise capacity in patients aged 12+ with Fontan circulation. Supports clinical programs: FUEL-2 phase 3 trial evaluating udenafil in adolescents 12–18, FALD study on long-term liver effects, and FUEL OLE study on long-term safety.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Mezzion Pharma company profile →
ReCor Medical
HQ: United States
Website
- Description: Provider of a therapeutic non-focused ultrasound system for renal denervation in resistant hypertension. Offers the PARADISE Percutaneous Renal Denervation System with a 6 French catheter and cylindrical transducer emitting circumferential ultrasound, the SonoWave 360 Transducer, HydroCooling System, clinical trials proving effectiveness, and reimbursement resources for coding and coverage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ReCor Medical company profile →
Arbor Surgical
HQ: United States
Website
- Description: Provider of cardiovascular medical device technologies focused on the heart valve replacement market.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Arbor Surgical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CathVision
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CathVision
2.2 - Growth funds investing in similar companies to CathVision
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CathVision
4.2 - Public trading comparable groups for CathVision
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →